Aurobindo Pharma Ltd.

₹1270.9

- 25.30 (-1.95%)

04:01 pm - close price

BSE: AUROPHARMA

NSE: AUROPHARMA

Industry: Pharmaceuticals & Drugs

House: Aurobindo

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 60.02Good: 5

✅

Adjusted EPS

Bad: 3Current: 60.02Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 14.39Good: 20

🟡

Current Ratio

Bad: 1Current: 1.85Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 11.15Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 16.38Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 60.02Good: 5

✅

Adjusted EPS

Bad: 3Current: 60.02Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 14.39Good: 20

🟡

Current Ratio

Bad: 1Current: 1.85Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 11.15Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 16.38Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	6850.52	7219.42	7351.78	7580.15	7567.02
Expenditure+	5699.15	5845.98	5750.47	5907.34	5947.45
Other Income+	116.33	186.98	162.52	135.62	220.93
Operating Profit	1151.37	1373.44	1601.31	1672.81	1619.57
Interest	56.55	68.18	75.55	89.43	111.04
Depreciation and Amortization	326.56	417.50	423.27	354.33	404.18
Profit Before Tax	812.03	1075.64	1262.42	1229.90	1323.89
Tax+	242.32	323.70	322.45	322.55	405.67
Net Profit	569.71	751.94	939.97	907.35	918.22

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	247746.20	234554.90	248553.80	290018.70	317237.30
Operational Expenses+	194412.20	190709.50	211367.40	231588.70	251409.40
Operating Profit	53334.00	43845.40	37186.40	58430.00	65827.90
Other Income	3808.50	3225.80	2905.90	5573.80	6218.50
OPM %	21.53	18.69	14.96	20.15	20.75
Depreciation and Amortisation	10553.90	11265.20	12445.80	15216.60	16494.20
Interest	744.90	486.40	1404.80	2897.10	4572.40
Profit Before Tax	73435.90	33727.40	26125.00	43799.90	50662.90
Tax	20097.70	7256.30	6848.50	12110.20	15827.20
Net Profit	53348.40	26481.50	19275.00	31729.70	34858.80

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	334013.10	336331.30	392125.00	438588.70	484920.10
Liabilities+	334013.10	336331.30	392125.00	438588.70	484920.10

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	33290.50	50164.80	23867.50	24345.20	39246.20
Cash from Investing Activity	5986.90	-32115.60	-39777.50	-42559.50	-18758.00
Cash from Financing Activity	-13649.40	-29692.70	18144.10	8004.20	1197.80
Net Cash Flow	25628.00	-11643.50	2234.10	-10210.10	21686.00
Opening Cash & Cash Equivalents	27468.20	53299.10	41625.10	43922.70	33854.30
Closing Cash & Cash Equivalents	53299.10	41625.10	43922.70	33854.30	55637.90

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	51.82	51.82	51.82	51.82	51.82	51.82	51.80	51.83	51.83	51.83
Public+	48.18	48.18	48.18	48.18	48.18	48.18	48.20	48.17	48.17	48.17
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	236859	247662	272208	269323	257962	248488	238622	244575	241944	259638

Corporate Actions

268 events in the last 3 years

Aurobindo Pharma Ltd.

₹1270.9

- 25.30 (-1.95%)

04:01 pm - close price

BSE: AUROPHARMA

NSE: AUROPHARMA

Industry: Pharmaceuticals & Drugs

House: Aurobindo

Overview

Ratios

Reported EPS

Bad: 2Current: 60.02Good: 5

✅

Adjusted EPS

Bad: 3Current: 60.02Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 14.39Good: 20

🟡

Current Ratio

Bad: 1Current: 1.85Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 11.15Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 16.38Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 60.02Good: 5

✅

Adjusted EPS

Bad: 3Current: 60.02Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 14.39Good: 20

🟡

Current Ratio

Bad: 1Current: 1.85Good: 2

🟡

Return On Equity (ROE)

Bad: 5Current: 11.15Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 16.38Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	6850.52	7219.42	7351.78	7580.15	7567.02
Expenditure+	5699.15	5845.98	5750.47	5907.34	5947.45
Other Income+	116.33	186.98	162.52	135.62	220.93
Operating Profit	1151.37	1373.44	1601.31	1672.81	1619.57
Interest	56.55	68.18	75.55	89.43	111.04
Depreciation and Amortization	326.56	417.50	423.27	354.33	404.18
Profit Before Tax	812.03	1075.64	1262.42	1229.90	1323.89
Tax+	242.32	323.70	322.45	322.55	405.67
Net Profit	569.71	751.94	939.97	907.35	918.22

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	247746.20	234554.90	248553.80	290018.70	317237.30
Operational Expenses+	194412.20	190709.50	211367.40	231588.70	251409.40
Operating Profit	53334.00	43845.40	37186.40	58430.00	65827.90
Other Income	3808.50	3225.80	2905.90	5573.80	6218.50
OPM %	21.53	18.69	14.96	20.15	20.75
Depreciation and Amortisation	10553.90	11265.20	12445.80	15216.60	16494.20
Interest	744.90	486.40	1404.80	2897.10	4572.40
Profit Before Tax	73435.90	33727.40	26125.00	43799.90	50662.90
Tax	20097.70	7256.30	6848.50	12110.20	15827.20
Net Profit	53348.40	26481.50	19275.00	31729.70	34858.80

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	334013.10	336331.30	392125.00	438588.70	484920.10
Liabilities+	334013.10	336331.30	392125.00	438588.70	484920.10

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	33290.50	50164.80	23867.50	24345.20	39246.20
Cash from Investing Activity	5986.90	-32115.60	-39777.50	-42559.50	-18758.00
Cash from Financing Activity	-13649.40	-29692.70	18144.10	8004.20	1197.80
Net Cash Flow	25628.00	-11643.50	2234.10	-10210.10	21686.00
Opening Cash & Cash Equivalents	27468.20	53299.10	41625.10	43922.70	33854.30
Closing Cash & Cash Equivalents	53299.10	41625.10	43922.70	33854.30	55637.90

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	51.82	51.82	51.82	51.82	51.82	51.82	51.80	51.83	51.83	51.83
Public+	48.18	48.18	48.18	48.18	48.18	48.18	48.20	48.17	48.17	48.17
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	236859	247662	272208	269323	257962	248488	238622	244575	241944	259638

Corporate Actions

268 events in the last 3 years

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.